The Food and Drug Administration approved Staar Surgical Co.'s (Nasdaq: STAA) injector system for use with implantable lenses to treat cataracts. The stock price leaped $1.26 to $2.75.
Staar Surgical's Injector System Approved
June 11, 2009 at 13:44 PM EDT
